Konec laboratorních krys: Jak technologie orgánů na čipu revolucionalizuje testování léků
In 2022, scientists connected four human tissues—heart, liver, bone, and skin—on a single chip with circulating fluid and immune cells, keeping them alive for weeks. The FDA announced plans in April 2025 to phase out many animal tests within 3–5 years. A kidney-on-a-chip identified 87% of drugs toxic to human kidneys. In 2024, Argenx submitted liver-on-a-chip data to the FDA as part of an IND application.
